Physician profile
Jean Murphy
NPI 1053372128
$1,276.02
in general payments reported to CMS, 2019-2025
15 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.08 · 2022: $99.62 · 2023: $384 · 2024: $505 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,096.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $475.07 | 2023-2025 | Watchman Flx, Axonics |
| Abbvie INC. | $184.14 | 2023-2025 | |
| Novo Nordisk INC | $135.12 | 2022-2025 | Rybelsus, Ozempic |
| Intuitive Surgical, INC. | $84.95 | 2025 | |
| Pfizer INC. | $77.75 | 2019-2023 | |
| Glaxosmithkline, LLC. | $72.51 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abiomed | $64.23 | 2023-2024 | Impella |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.37 | 2023-2025 | Xifaxan |
| Amgen INC. | $32.76 | 2023-2025 | Evenity, Prolia, Repatha |
| Horizon Therapeutics Plc | $21.52 | 2023 | Krystexxa |
| Allergan, INC. | $21.31 | 2019 | |
| Seqirus USA INC | $19.52 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $18.58 | 2024 | Breztri |
| Astellas Pharma US INC | $18.17 | 2024 | Veozah |
| Lilly USA, LLC | $16.02 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.